Biblio
“Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.
, “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
, “White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.”, J Alzheimers Dis, vol. 63, no. 2, pp. 515-527, 2018.
, “Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 467-475, 2023.
, “Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning.”, J Alzheimers Dis, vol. 53, no. 1, pp. 117-25, 2016.
, “The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
, “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
, “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
, “Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.”, J Alzheimers Dis, vol. 61, no. 2, pp. 689-703, 2018.
, “Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1509-1517, 2017.
, “Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.”, J Alzheimers Dis, vol. 60, no. 3, pp. 859-866, 2017.
, “Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 113-21, 2016.
, “The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.”, J Alzheimers Dis, 2024.
, “Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
, “Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.”, J Alzheimers Dis, vol. 55, no. 2, pp. 717-725, 2017.
, “Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 163-170, 2023.
, “Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 74, no. 2, pp. 435-439, 2020.
, “Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.”, J Alzheimers Dis, 2024.
, “Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 127-33, 2016.
, “Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 53, no. 1, pp. 315-25, 2016.
, “Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1075-1088, 2018.
, “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
, “Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1589-1600, 2017.
, “Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1551-1560, 2016.
, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
,